Evidence map›Paper›PMID 24324208›Full record

ReviewInternational immunology2014

Foxp3⁺ T(reg) cells in humoral immunity.

James B Wing, Shimon Sakaguchi

Abstract readReview
In one paragraph

Review in International immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Engineering nanoparticle therapeutics for food allergy.The Journal of allergy and clinical immunology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Review
  16. Omega 3 Fatty Acid and Skin Diseases.Frontiers in immunology · 2020
    Review
  17. Regulatory T cells induce CD4Cancer immunology, immunotherapy : CII · 2019
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

James B WingDepartment of Experimental Immunology, WPI Immunology Frontier Research Center, Osaka University, Suita 565-0871, Osaka, Japan.
Shimon Sakaguchi
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T(reg) cells are essential for the maintenance of immune homeostasis and prevention of autoimmunity. In humoral immune responses, loss of T(reg) cell function causes increased levels of serum autoantibodies, hyper-IgE, spontaneous generation of germinal centres, and enhanced numbers of specialised T follicular helper cells (T(fh) cells) controlled by the lineage-defining transcription factor BCL-6 (B-cell lymphoma 6). Recent studies have demonstrated that a subset of T(reg) cells [T follicular regulatory (T(freg)) cells] are able to co-opt the follicular T-cell program by gaining expression of BCL-6 and travelling to the follicle where they have an important role in the control of expansion of T(fh) cells and the germinal centre reaction. However, the mechanisms by which they exert this control are still under investigation. In this review, we discuss the effects of T(reg) cells on humoral immunity and the mechanisms by which they exert their regulatory function.

Indexed as

AnimalsAutoantibodiesHomeostasisHumansImmune ToleranceImmunity, HumoralProto-Oncogene Proteins c-bcl-6T-Lymphocytes, RegulatoryT-Lymphocyte SubsetsAutoantibodiesProto-Oncogene Proteins c-bcl-6antibodyCTLA-4T-follicular helper cellsT-follicular regulatory cells

Identifiers

PMID24324208
PMCPMC7108613
OpenAlexW2151226131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.